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Cationic (arene)ruthenium-based tetranuclear complexes of the general formula [Ru4(h6-p-
cymene)4(m-N\N)2(m-OO\OO)2]4þ were obtained from the dinuclear (arene)ruthenium complexes
[Ru2(h6-p-cymene)2(m-OO\OO)2Cl2] (p-cymene¼ 1-methyl-4-(1-methylethyl)benzene, OO\OO¼
5,8-dihydroxy-1,4-naphthoquinonato(2), 9,10-dihydroxy-1,4-anthraquinonato(2), or 6,11-dihydroxy-
naphthacene-5,12-dionato(2)) by reaction with pyrazine or bipyridine linkers (N\N¼ pyrazine, 4,4’-
bipyridine, 4,4’-[(1E)-ethene-1,2-diyl]bis[pyridine]) in the presence of silver trifluoromethanesulfonate
(CF3SO3Ag) (Scheme). All complexes 4 – 12 were isolated in good yield as CF3SO3 salts, and
characterized by NMR and IR spectroscopy. The host – guest properties of the metallarectangles
incorporating 4,4’-bipyridine and (4,4’-[(1E)-ethene-1,2-diyl]bis[pyridine] linkers were studied in
solution by means of multiple NMR experiments (1D, ROESY, and DOSY). The largest metal-
larectangles 10 – 12 incorporating (4,4’-[(1E)-ethene-1,2-diyl]bis[pyridine] linkers are able to host an
anthracene, pyrene, perylene, or coronene molecule in their cavity, while the medium-size metal-
larectangles 7 – 9 incorporating 4,4’-bipyridine linkers are only able to encapsulate anthracene. However,
out-of-cavity interactions are observed between these 4,4’-bipyridine-containing rectangles and pyrene,
perylene, or coronene. In contrast, the small pyrazine-containing metallarectangles 4 – 6 show no
interaction in solution with this series of planar aromatic molecules.
Introduction. – Half-sandwich complexes of ruthenium (Ru) and to a lesser extent
osmium (Os) have received considerable attention, especially as catalysts [1], as
biological agents [2], and recently as building blocks in supramolecular chemistry [3].
Their ability to generate a pre-organized arrangement with appropriate multidentate
bridging ligands and rigid linkers have allowed the controlled formation of various
supramolecular constructions, such as metallacycles [4], metallarectangles [5], metal-
laprisms [6], and metallacubes [7].
In coordination and organometallic chemistry, quinones are attracting a lot of
interest [8]. Their numerous applications in organic chemistry [9], physical chemistry
[10], and biology [11] are well known, and moreover, these multifunctional ligands are
becoming popular for the synthesis of complexes with (h6-arene)ruthenium units [12].
The commercially available quinone derivatives, 5,8-dihydroxy-1,4-naphthoquinone
(H2dhnq), 9,10-dihydroxy-1,4-anthraquinone (H2dhaq), and 6,11-dihydroxynaphtha-
cene-5,12-dione (H2dhtq) have been used to form dinuclear species with Ru metals
[13]. However, the corresponding dinuclear complexes incorporating [Ru(h6-arene)]
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units remain scarce in the literature, and only [Ru2(h6-p-cymene)2{m-[5,8-di(hydroxy-
kO)-1,4-naphthoquinonato(2)-kO1 :kO4]}Cl2] [14] and [Ru2(h6-p-cymene)2{m-[9,10-
di(hydroxy-kO)-1,4-anthraquinonato(2)-kO1 :kO4]}Cl2] have been synthesized so far
[15] (p-cymene¼ 1-methyl-4-(1-methylethyl)benzene).
Recently, we reported the synthesis of a series of cationic tetranuclear metal-
larectangles of the general formula [Ru4(h6-p-cymene)4(m-N\N)2{m-[5,8-di(hydroxy-
kO)-1,4-naphthoquinonato(2)-kO1 :kO4]}2]4þ (N\N¼ pyrazine, 4,4’-bipyridine, 4,4’-
[(1E)-ethene-1,2-diyl]bis[pyridine]). The ability of these metallarectangles to host
pyrene in solution was studied [16]. In the case of [Ru4(h6-p-cymene)4[m-(pyrazine-
kN1 :kN4)]2{m-[5,8-di(hydroxy-kO)-1,4-naphthoquinonato(2)-kO1 :kO4]}2]4þ 4, no in-
teraction between the metallarectangle and pyrene was observed. However, in the case
of [Ru4(h6-p-cymene)4[m-(4,4’-bipyridine-kN1 :kN1’)]2{m-[5,8-di(hydroxy-kO)-1,4-
naphthoquinonato(2)-kO1 :kO4]}2]4þ 7, interactions occurred on the outside of the
rectangular assembly, while in [Ru4(h6-p-cymene)4{m-{4,4’-[(1E)-ethene-1,2-diyl]bis-
[pyridine]-kN1 :kN1’}}2{m-[5,8-di(hydroxy-kO)-1,4-naphthoquinonato(2)-kO1 :kO4]}2]4þ
10, the pyrene molecule was found inside the hydrophobic cavity of the metal-
larectangle, thus giving rise to a host – guest system. We now extended this study to
three other guest molecules, anthracene, perylene, and coronene, with not only the
already known 5,8-dihydroxy-1,4-naphthoquinonato(2) containing metallarectangles
but as well with 9,10-dihydroxy-1,4-anthraquinonato(2) and 6,11-dihydroxynaph-
thacene-5,12-dionato(2) bridging ligands, thus generating the cationic tetranuclear
metallarectangles [Ru4(h6-p-cymene)4(m-N\N)2(m-OO\OO)2]4þ (OO\OO¼ 9,10-
dihydroxy-1,4-anthraquinonato(2), 6,11-dihydroxynaphthacene-5,12-dionato(2);
N\N¼ pyrazine, 4,4’-bipyridine, 4,4’-[(1E)-ethene-1,2-diyl]bis[pyridine]).
Results and Discussion. – The synthesis of cationic tetranuclear metallarectangles
involves the dinuclear (h6-arene)ruthenium precursors [Ru2(h6-p-cymene)2(m-OO\
OO)2Cl2] 1 – 3. Whereas the syntheses of the dinuclear metallaclips 1 [14] and 2 [15]
have already been reported, the synthesis of [Ru2(h6-p-cymene)2{m-[6,11-di(hydroxy-
kO)naphthacene-5,12-dionato(2)-kO5 :kO12]}Cl2] (3) is new. Complex 3 is charac-
terized by NMR, UV/VIS, and IR spectroscopy. As expected, the 1H-NMR spectra of 3
show two doublets at d(H) 8.50 and 7.72 corresponding to the H-atoms of the 6,11-
dihydroxynaphthacene-5,12-dionato(2) bridging ligand along with the signals
associated with the h6-p-cymene ligands.
These dinuclear bridged (h6-arene)ruthenium complexes 1 – 3 react in MeOH at
room temperature in the presence of CF3SO3Ag (halide scavenger) with different N\
N donor ligands (N\N¼pyrazine, 4,4’-bipyridine, 4,4’-[(1E)-ethene-1,2-diyl]bis[pyr-
2
idine]) to give the cationic tetranuclear metallarectangles 4 – 12 which are isolated as
CF3SO3 salts (Scheme).
The 1H-NMR spectra of 4 – 6 display a s due to the pyrazine H-atoms. Unlike free
pyrazine, where the H-atom signal is found at d(H) 8.57 in CD3CN, the corresponding
signal of 4 – 6 appears slightly shifted upfield at d(H) 8.46. The 1H-NMR spectra of 7 –
9 show two doublets due to the 4,4’-bipyridine H-atoms with an upfield shift Dd of ca.
0.2 as compared with the free 4,4’-bipyridine in CD3CN. The same upfield shiftDd of ca.
0.2 is observed for the H-atoms of the 4,4’-[(1E)-ethene-1,2-diyl]bis[pyridine] linkers
in complexes 10 – 12. Upon formation of the cationic tetranuclear metallarectangles,
theMe and i-Pr signals of the h6-p-cymene ligands in 4 – 12 remain almost unchanged as
compared to those of complexes 1 – 3, while the aromatic H-atoms of the h6-p-cymene
ligands are slightly shifted downfield. Similarly, the H-atom signals of the bridging 5,8-
dihydroxy-1,4-naphthoquinonato(2), 9,10-dihydroxy-1,4-anthraquinonato(2), and
6,11-dihydroxynaphthacene-5,12-dionato(2) ligands in all metallarectangles 4 – 12
are shifted downfield as compared to their parent complexes 1 – 3.
In the metallarectangles 5, 8, and 11, the asymmetry of the 9,10-dihydroxy-1,4-
anthraquinonato(2) bridging ligand allows the formation of two isomers. Indeed, the
presence of two isomers is quite obvious in the case of 5 in which two distinct sets of
signals for the 9,10-dihydroxy-1,4-anthraquinonato(2) ligands are observed in the
1H-NMR spectrum (CD3CN). However, the signals of the h6-p-cymene and pyrazine
ligands remain equivalent despite the presence of these two isomers 5 and 5’ (Fig. 1). In
the case of 8 and 11, in which the two 9,10-dihydroxy-1,4-anthraquinonato(2) bridges
are far away from each other, only the singulet of the 9,10-dihydroxy-1,4-
anthraquinonato(2) ligands is observed as nonequivalent signals. All other signals
show no sign of the presence of the two isomers and give rise to only one set of signals
for both isomers.
The IR spectra of 4 – 12 are dominated by absorptions of the coordinatedN\N and
OO\OO ligands which are only slightly shifted as compared to the IR absorptions of
the free ligands. In addition to the N\N and OO\OO signals, strong absorptions due
to the stretching vibrations of the CF3SO3 anions (1260s, 1030s, and 638m cm1) are
also observed in the IR spectra of the salts [4 – 12] [CF3SO3]4. The electronic




energy band centered at 320 nm, which is assigned to ligand-localized or intra-ligand
p!p* transition as well as broad low-energy bands associated to metal-to-ligand
charge-transfer (MLCT) transitions. In 1 – 3, only one MLCT band is found at ca.
600 nm, while in metallarectangles 4 – 12, an additional band centered at ca. 400 nm is
observed as well (Fig. 2).
As we were unable to grow crystals for X-ray measurements, the cavity sizes of the
different metallarectangles were estimated by molecular modeling and from analogous
Fig. 1. Schematic representation of the two isomers of 5
Fig. 2. UV/VIS Spectra of 1 – 12 (105 m) in CH2Cl2
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structures incorporating the same bridging and connecting ligands. The pyrazine series
possess a cavity of ca. 8.4 7.0 2 (Ru-to-Ru edges), while the cavity sizes of the 4,4’-
bipyridine and 4,4’-[(1E)-ethene-1,2-diyl]bis[pyridine] series are expected to be ca.
8.4 11.2 and 8.4 13.6 2, respectively (Fig. 3).
To study the ability of the hydrophobic cavity of the metallarectangles 4 – 12 to
encapsulate guest molecules in solution, we performed various NMR experiments.
1H-NMR Spectra of 1 :1 mixtures of metallarectangles with planar aromatic molecules
(pyrene, anthracene, perylene, and coronene) were measured. In the case of the
pyrazine-containing metallarectangles 4 – 6, no shifts of the chemical shifts were
observed for the H-atoms of the host and of the aromatic molecule in CD3CN. The
result is quite different with the larger metallarectangles 7 – 12 in which some H-atoms
of the rectangle and of the aromatic molecule are shifted as compared to their initial
1H-NMR spectra (Fig. 4). Consequently, these observations prompted us to further
investigate the hosting potential of the metallarectangles 7 – 12 in solution by diffusion-
Fig. 3. Estimated cavity size of the different metallarectangles
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ordered NMR spectroscopy (DOSY). DOSY Measurement is a powerful tool for
studying host – guest association in solution [17]. The diffusion coefficient depends on
the shape and size of the molecules. Therefore, in a host – guest system in which the
guest is perfectly encapsulated in the cavity of the host without significantly affecting
the size and shape of the host, the diffusion coefficient of the guest host adduct will be
almost identical to the diffusion coefficient of the host alone. On the other hand, in a
host – guest system in which the guest interacts with the host but not in a guest host
fashion, the host and the guest will keep their individual diffusion coefficients.
Room-temperature DOSY measurements of the 4,4’-bipyridine-containing metal-
larectangles 7 – 9 in the presence of anthracene, pyrene, perylene, and coronene suggest
out-of-cavity interactions between the different rectangles and the aromatic molecules.
However, at  408, the same DOSYexperiment with anthracene and metallarectangle
7 clearly shows that anthracene diffuses at almost the same coefficient as the host
(Fig. 5), thus supporting an in-cavity location of anthracene. To confirm this
assumption, a ROESY (rotating-frame NOE spectroscopy) measurement at  408
was performed (Fig. 5). The 1H-ROESY shows that some H-atoms of anthracene are
in close proximity to the H-atoms of the 5,8-dihydroxy-1,4-naphthoquinonato(2) and
4,4’-bipyridine ligands which confirms, together with the DOSY experiment at  408,
the presence of anthracene in the cavity of 7. All other aromatic molecules (pyrene,
perylene, and coronene) do not show in-cavity interactions with metallarectangles 7 – 9,
even at low temperature, which fit with out-of-cavity interactions. In contrast, 4,4’-
[(1E)-ethene-1,2-diyl]bis[pyridine]-containing metallarectangles 10 – 12 show in-cavity
interactions with these large planar aromatic molecules.
Fig. 4. 1H-NMR Spectra (258, CD3CN) a) of pyrene, b) pyrene þ 1 equiv. of 7, and c) of 7
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DOSY Experiments of anthracene with metallarectangles 10 – 12 show both in-
cavity and out-of-cavity interactions at room temperature, as opposed to pyrene,
perylene, and coronene for which in-cavity interaction dominates. As an example, the
DOSY spectra of coronene, metallarectangle 10 and a 1 :1 mixture of coronene, and 10
in CD3CN at room temperature are presented in Fig. 6. These experiments clearly show
that at room temperature, coronene/10 1 :1 and 10 possess almost identical diffusion
coefficients, which confirm the encapsulation of coronene in the hydrophobic cavity of
10 and the formation of a coronene 10 adduct.
In summary, 1H-NMR, DOSY and ROESY studies revealed that no meaningful
interaction occurs between the pyrazine-containing metallarectangles 4 – 6 and planar
aromatic molecules, while out-of-cavity interactions are prevailing in the case of the
4,4’-bipyridine-containing metallarectangles 7 – 9, with the exception of anthracene
which can do both in-cavity and out-of-cavity interactions with these metallarectangles.
On the other hand, in-cavity interactions take place for the 4,4’-[(1E)-ethene-1,2-
diyl]bis[pyridine]-containing metallarectangles 10 – 12, thus giving rise to guesthost
systems.
Therefore, to gain further information on the hosting ability of 10 – 12 in solution, a
series of 1H-NMR titration in CD3CN solution with pyrene, perylene, and coronene
Fig. 5. DOSY (bottom) and ROESY (top) NMR plots of 7þ 1 equiv. of anthracene at  408 (CD3CN)
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was performed. Upon gradual addition of guest molecule (0.0 – 20.0 equiv. of pyrene,
perylene, or coronene) to a CD3CN solution of metallarectangles 10 – 12 (4.0 mm),
1H-NMR spectra were recorded. Then, the chemical-shift changes (Dd) of one chosen
signal of the metallarectangles 10 – 12 (e.g., of the ethenediyl moiety) vs. the molar ratio
of the guest to the metallarectangle were plotted (Fig. 7). Considering the DOSY
experiments reported previously, and accordingly assuming a 1 :1 system, and by using
theDd value at known guest/host molar ratio with the help of the nonlinear least-square
fitting program winEQNMR2 [18], the stability constants of association (Ka) together
with the free energies (DG8) were estimated (Table). The estimated stability constants
are comprised between 52000 m1 and 69000 m1, which imply a relatively strong
affinity between the host and the guest – metallarectangle and aromatic molecules –
Fig. 6. DOSY 1H-NMR plots (258, CD3CN) of coronene, 10, and 10þ 1 equiv. of coronene
Table. Stability Constants and Free Energies for the Encapsulation of Pyrene, Perylene, and Coronene in
Metallarectangles 10 – 12 (CD3CN at 258, 4.0 mm of host)
Guest host Ka [104 m1] DG8 [kcal mol1]
Pyrene 10 5.8 0.9  6.48 0.05
Perylene 10 5.5 0.4  6.46 0.02
Coronene 10 6.9 0.6  6.60 0.02
Pyrene 11 6.8 0.8  6.59 0.04
Perylene 11 5.7 0.5  6.47 0.02
Coronene 11 5.6 0.7  6.47 0.02
Pyrene 12 5.2 0.9  6.43 0.02
Perylene 12 5.6 0.4  6.47 0.02
Coronene 12 6.2 0.7  6.53 0.04
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which, however, suggest no selectivities or preferences by the metallarectangle among
these guests (pyrene, perylene, and coronene). This nonspecificity of the metal-
larectangles 10 – 12 for these planar aromatic molecules in MeCN was further
confirmed by a competition experiment in which a 1 :1 : 1 :1 mixture of pyrene,
perylene, coronene, and 10 was involved. A 1H-DOSYexperiment shows that the three
potential guest molecules are competing equally for the hydrophobic cavity of 10,
which is not surprising given their comparable stability constants.
To conclude these host – guest studies, we performed a fluorescence-emission
titration of perylene with metallarectangle 10. Perylene has been intensively used as
fluorescent probe, and its basic fluorescence is well documented [19]. The fluorescence
quenching of perylene via exciplex formation [20] or energy transfer [21] in solution has
been also studied in detail, and we propose here to see whether or not such quenching
by encapsulation of perylene inside the cavity of a metallarectangle 10 occurred. The
emission spectra of a CH2Cl2 solution of perylene (107 m, 350 nm as excitation
wavelength) upon gradual addition of metallarectangle 10 (0.0 – 10 equiv.) were
recorded (Fig. 8). A quenching of the perylene fluorescence is clearly observed when
10 is added. This quenching of the fluorescence of perylene can be explained by two
effects. Firstly, as the guest goes into the cavity of the metallarectangle 10, there is a loss
of excitation energy received by the guest molecule: a part of the energy can be
absorbed by the metallarectangle and consequently, the perylene molecule encapsu-
lated in the metallarectangle is less excited and, therefore, cannot reemit the same
energy as compared to its free state. Secondly, the quenching can result from energy
transfer from perylene to metallarectangle 10. Indeed, due to a good spectral overlap of
absorbance of metallarectangle 10 with the perylene emission, energy transfer can
spontaneously take place (Fig. 9), thus leading to a decrease in the emission energy of
perylene and ultimately to fluorescence quenching [22].
Fig. 7. 1H-NMR Chemical-shift changes Dd (258, CD3CN) of the H-atoms of the ethenediyl moiety of 12
upon addition of pyrene to 12
10
Conclusion. – This study reveals that tetranuclear (arene)ruthenium complexes
containing OO\OO-bridges (5,8-dihydroxy-1,4-anthraquinonato(2), 9,10-dihy-
Fig. 8. Fluorescence-emission titration of perylene (107 m in CH2Cl2) by metallarectangle 10 (excitation
wavelength 350 nm)
Fig. 9. Normalized absorbance spectrum of metallarectangle 10 and fluorescence spectrum of perylene
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droxy-1,4-anthraquinonato(2), and 6,11-dihydroxynaphthacene-5,12-dionato(2))
and N\N-linkers (pyrazine, 4,4’-bipyridine, 4,4’-[(1E)-ethene-1,2-diyl]bis[pyridine])
can be designed to accommodate guest molecules inside their cavity. Various NMR
experiments showed that the small pyrazine-containing metallarectangles 4 – 6 do not
interact with planar aromatic molecules (anthracene, pyrene, perylene, and coronene),
while the more spacious 4,4’-bipyridine and 4,4’-[(1E)-ethene-1,2-diyl]bis[pyridine]-
containing metallarectangles 7 – 12 give both in-cavity and out-of-cavity interactions
with these aromatic molecules. Encapsulation of perylene in the hydrophobic cavity of
10 strongly quenches the fluorescence of perylene in solution, which confirms the great
potential of such metallarectangles for applications in host – guest chemistry.
We thank Johnson Matthey Research Center for a generous loan of ruthenium chloride hydrate.
Experimental Part
General. The [Ru(h6-p-cymene)Cl2]2 [23], the dinuclear [Ru(arene)]complexes [Ru2(h6-p-cyme-
ne)2(m-OO\OO)Cl2] 1 and 2 (OO\OO¼ 5,8-dihydroxy-1,4-naphthoquinonato(2) [14], 9,10-dihy-
droxy-1,4-anthraquinonato(2) [15]) and the metallarectangles 4, 7, and 10 [16] were prepared
according to published methods. All other reagents were commercially available (Sigma –Aldrich) and
used as received. UV/VIS Spectra: Uvikon-930 spectrophotometer; precision cells made of quartz
(1 cm); lmax (e [m1 · cm1]) in nm. Fluorescence spectra: Perkin-Elmer-LS50B luminescence spectrom-
eter; precision cells made of quartz (1 cm). IR Spectra: Perkin-Elmer-1720X FT-IR spectrometer; KBr
pellets; n˜ in cm1. 1H- and 13C{1H}-NMR Spectra and 1H-ROESY: Bruker-Avance II-400 spectrometer;
residual protonated solvent as internal standard (CDCl3: d(H) 7.26; CD3CN: d(H) 1.94), J in Hz.
Microanalyses were performed by the Laboratory of Pharmaceutical Chemistry, University of Geneva,
Switzerland.
DOSY-NMR Experiments. For all DOSY experiments, the temp. was regulated at 298 or 233 K, the
airflow was increased to 670 l ·min1, and the NMR tube was not spun. The diffusion NMR experiments
were performed with a standard pulsed-gradient stimulated echo (LED-PFGSTE) sequence and a
bipolar gradient [17]. DOSY Spectra were generated by using the TopSpin 2.0 software package
(Bruker). Experimental parameters were D¼ 50.0 ms (diffusion delay), t¼ 1.0 ms (gradient recovery
delay), and Te¼ 5.0 ms (eddy current recovery delay). For each data set, 4096 complex points were
collected, and the gradient dimension was sampled by means of 16 experiments in which the gradient
strength was linearly incremented from 1.0 to 50.8 G · cm1. The gradient duration d/2 was adjusted to
observe a near-complete signal loss at 50.8 G · cm1. Typically, the d/2 delay was chosen in the 1.2 – 2.0 ms
range. A 1.0 s recycle delay was used between scans for data shown. For each data set, the spectral axis
was processed with an exponential function (3 – 5 Hz line broadening), and Fourier transform was
applied to obtain 4096 real points. The DOSY reconstruction was realized with 256 points in the diffusion
dimension. The number of scans ranged from 8 to 64 and was adapted to each sample. The experimental
time ranged from 4 to 30 min.
ROESY-NMR Experiments. For the ROESY experiment shown, the temp. was regulated at 233 K,
and the NMR tube was not spun. The ROESY experiment was performed by means of a gradient-
selected ROESY [24], with the Tr-ROESY scheme [25] for efficient TOCSY transfer suppression.
Experimental parameters were tm¼ 200 ms (mixing time), d¼ 500 ms (gradient length), G0¼ 1.0 G ·
cm1, G1¼ 3.0 G · cm1, G2¼ 6.0 G · cm1 (gradient strength), and tp¼ 100 ms (selective pulse, Seduce-
1). A total of 8192 complex points were collected. A 3 s recycle delay was used. The spectral axis was
processed with an exponential function (3 Hz line broadening), and Fourier transform was applied to
obtain 8192 real points. The number of scans was 1024 and the experimental time ca. 90 min.
Dinuclear Metallaclip: Dichloro{m-[6,11-di(hydroxy-kO)naphthacene-5,12-dionato(2)-kO5 :
kO12]}bis[1,2,3,4,5,6-h)-1-methyl-4-(1-methylethyl)benzene]diruthenium (3). A mixture of [Ru(h6-p-
cymene)Cl2]2 (145.0 mg, 0.23 mmol), anh. AcONa (38.4 mg, 0.46 mmol), and 6,11-dihydroxynaphtha-
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cene-5,12-dione (66.8 mg, 0.23 mmol) in EtOH (25 ml) is stirred under reflux for 24 h. Then the
precipitate is filtered and washed with EtOH, H2O, acetone, Et2O, and pentane: 3 (177 mg, 93%). Blue
solid. UV/VIS (1.0 · 105 m, acetone): 326 (3.06 · 104), 384 (2.04 · 104), 416 (1.02 · 104), 594 (1.19 · 104), 648
(0.16 · 104). IR: 3055w (nCsp2H), 1546s (nC¼O), 850s (dCsp2H).
1H-NMR (400 MHz, CDCl3): 8.50 (d, 3J¼
8.1, 4 Hdhtq); 7.72 (d, 3J¼ 8.1, 4 Hdhtq); 5.68 (d, 3J¼ 5.4, 4 Hp-cym); 5.33 (d, 3J¼ 5.4, 4 Hp-cym); 3.06 (sept., 3J¼
3.0, 2 Me2CH); 2.42 (s, 2 Me); 1.57 (d, 2Me2CH). 13C-NMR (100 MHz, CDCl3): 169.4 (CO); 134.5
(CHdhtq); 131.1 (CHdhtq); 126.8 (Cdhtq); 99.8 (Cp-cym); 97.4 (Cp-cym); 83.1 (CHp-cym); 79.3 (CHp-cym); 30.9
(Me2CH); 18.0 (Me). Anal. calc. for C38H36Cl2O4Ru2 (829.75): C 55.01, H 4.37; found: C 55.98, H 4.98.
Metallarectangles 4 – 12 : General Procedure. A mixture of 1 equiv. of 1 – 3 (0.21 mmol), 2 equiv. of
CF3SO3Ag (0.43 mmol), and 1 equiv. of the correspondingN\N linker (0.21 mmol) in MeOH (40 ml) is
stirred at 608 for 24 h, and then the soln. is filtered to remove AgCl. The solvent is evaporated, and the




(1 :4) ([5] [CF3SO3]4): Yield 169 mg (74%). UV/VIS (1.0 · 105 m, acetone): 304 (3.52 · 105), 442 (0.25 ·
105), 625 (0.12 · 105), 696 (0.11 · 105). IR: 3055w (nCsp2H), 1546s (nC¼O), 1261s (nCsp3F), 850s (dCsp2H).
1H-NMR (400 MHz, CD3CN): 8.82 (d, 3J¼ 8.5, 2 Hdhaq); 8.59 (d, 3J¼ 7.9, 2 Hdhaq’); 8.58 (s, 8 Hpyrazine); 7.93
(d, 3J¼ 8.5, 2 Hdhaq); 7.82 (d, 3J¼ 7.9, 2 Hdhaq’); 7.17 (s, 2 Hdhaq); 7.05 (s, 2 Hdhaq’); 5.91 (d, 3J¼ 5.6, 4 Hp-cym);
5.86 (d, 3J¼ 5.6, 4 Hp-cym); 5.80 – 5.84 (m, 8 Hp-cym); 2.82 (sept., 3J¼ 2.9, 4 Me2CH); 2.13 (s, 4 Me); 1.45 (d,
3J¼ 2.9, 4Me2CH). 13C-NMR (100 MHz, CD3CN): 172.3 (CO); 171.2 (CO); 145.7 (CHpyrazine); 139.2
(CHdhaq); 132.7 (CHdhaq); 133.3 (Cdhaq); 133.0 (Cdhaq); 128.1 (CHdhaq); 104.2 (Cp-cym); 100.1 (Cp-cym); 85.9
(CHp-cym); 85.1 (CHp-cym); 83.2 (CHp-cym); 83.8 (CHp-cym); 31.5 (Me2CH); 22.7 (Me2CH); 17.6 (Me). Anal.
calc. for C80H76F12N4O20Ru4S4 (2173.41): C 44.21, H 3.52, N 2.58; found: C 43.05, H 3.22, N 2.41.
Bis{m-[6,11-di(hydroxy-kO)naphthacene-5,12-dionato(2)-kO5 :kO12]tetrakis[(1,2,3,4,5,6-h)-1-
methyl-4-(1-methylethyl)benzene]bis[m-(pyrazine-kN1 :kN4)]tetraruthenium 1,1,1-Trifluoromethanesul-
fonate (1 :4) ([6] [CF3SO3]4): Yield 178 mg (73%). UV/VIS (1.0 · 105 m, acetone): 312 (3.68 · 105), 380
(0.42 · 105), 530 (0.14 · 105), 568 (0.21 · 105), 613 (0.24 · 105). IR: 3060w (nCsp2H), 1542s (nC¼O), 1260s
(nCsp3F), 850s (dCsp2H).
1H-NMR (400 MHz, CD3CN): 8.57 (d, 3J¼ 8.4, 8 Hdhtq); 8.47 (s, 8 Hpyrazine); 7.82
(d, 3J¼ 8.4, 8 Hdhtq); 5.90 (d, 3J¼ 5.8, 8 Hp-cym); 5.76 (d, 3J¼ 5.8, 8 Hp-cym); 2.93 (sept., 3J¼ 3.0, 4 Me2CH);
2.16 (s, 4 Me); 1.29 (d, 3J¼ 3.0, 4Me2CH). 13C-NMR (100 MHz, CD3CN): 169.9 (CO); 149.4 (CHpyrazine);
134.2 (CHdhtq); 128.4 (CHdhtq); 107.8 (Cdhtq); 107.8 (Cp-cym); 106.1 (Cp-cym); 100.7 (Cdhtq); 84.6 (CHp-cym);
84.5 (CHp-cym); 31.3 (Me2CH); 22.4 (Me2CH); 17.8 (Me). Anal. calc. for C88H80F12N4O20Ru4S4 (2273.50):
C 46.49, H 3.52, N 2.46; found: C 47.65, H 3.78, N 2.80.
[Bis[m-(4,4’-bipyridine-kN1 :kN1’)]bis{m-[9,10-di(hydroxy-kO)anthracene-1,4-dionato(2)-kO1 :kO4]}-
tetrakis[(1,2,3,4,5,6-h)-1-methyl-4-(1-methylethyl)benzene]tetraruthenium 1,1,1-Trifluoromethanesulfo-
nate (1 :4) ([8] [CF3SO3]4): Yield 192 mg (77%). UV/VIS (1.0 · 105 m, acetone): 312 (3.58 · 105), 418
(0.39 · 105), 608 (0.16 · 105), 658 (0.18 · 105). IR: 3069w (nCsp2H), 1539s (nC¼O), 1260s (nCsp3F), 850s
(dCsp2H).
1H-NMR (400 MHz, CD3CN): 8.60 – 8.64 (m, 4 HdhaqþHdhaq’); 8.46 (d, 3J¼ 8.6, 8 Ha); 7.91 – 7.95
(m, 4 HdhaqþHdhaq’); 7.60 (d, 3J¼ 8.6, 8 Hb); 7.21 (s, 2 Hdhaq); 7.20 (s, 2 Hdhaq’); 5.78 (d, 3J¼ 5.8, 4 Hp-cym);
5.73 (d, 3J¼ 5.8, 4 Hp-cym); 5.54 – 5.58 (m, 8 Hp-cym); 2.85 (sept., 3J¼ 2.8, 4 Me2CH); 2.11 (s, 4 Me); 1.30 (d,
3J¼ 2.8, 4Me2CH). 13C-NMR (100 MHz, CD3CN): 171.2 (CO); 170.3 (CO); 153.8 (CHa); 145.7 (Cbpy);
138.7 (CHdhaq); 134.4 (CHdhaq); 134.0 (Cdhaq); 133.9 (Cdhaq); 128.3 (CHdhaq); 123.9 (CHb); 104.6 (Cp-cym);
100.5 (Cp-cym); 85.2 (CHp-cym); 84.9 (CHp-cym); 83.7 (CHp-cym); 83.7 (CHp-cym); 31.4 (Me2CH); 22.5
(Me2CH); 17.6 (Me). Anal. calc. for C92H84F12N4O20Ru4S4 (2325.55): C 47.52, H 3.61, N 2.41; found: C
45.48, H 3.27, N 2.21.
[Bis[m-(4,4’-bipyridine-kN1 :kN1’)]bis{m-[6,11-di(hydroxy-kO)naphthacene-5,12-dionato(2)-kO5 :
kO12]}tetrakis[(1,2,3,4,5,6-h)-1-methyl-4-(1-methylethyl)benzene]tetraruthenium 1,1,1-Trifluoromethane-
sulfonate (1 :4) ([9] [CF3SO3]4): Yield 211 mg (81%). UV/VIS (1.0 · 105 m, acetone): 312 (3.58 · 105), 384
(0.34 · 105), 533 (0.14 · 105), 573 (0.19 · 105), 618 (0.20 · 105). IR: 3071w (nCsp2H), 1543s (nC¼O), 1262s
(nCsp3F), 850s (dCsp2H).
1H-NMR (400 MHz, CD3CN): 8.69 (d, 3J¼ 8.6, 8 Hdhtq); 7.93 (d, 3J¼ 7.9, 8 Ha);
7.57 (d, 3J¼ 7.9, 8 Hb); 7.52 (d, 3J¼ 8.6, 8 Hdhtq); 5.85 (d, 3J¼ 5.8, 8 Hp-cym); 5.63 (d, 3J¼ 5.8, 8 Hp-cym); 2.88
(sept., 3J¼ 2.9, 4 Me2CH); 2.16 (s, 4 Me); 1.37 (d, 3J¼ 2.9, 4Me2CH). 13C-NMR (100 MHz, CD3CN):
13
170.0 (CO); 153.7 (CHa); 134.5 (Cbpy); 134.0 (CHdhtq); 128.2 (CHb); 123.9 (CHdhtq); 108.0 (Cdhtq); 104.7
(Cp-cym); 100.7 (Cp-cym); 85.1 (CHp-cym); 83.5 (CHp-cym); 31.4 (Me2CH); 22.4 (Me2CH); 17.8 (Me). Anal.
calc. for C100H88F12N4O20Ru4S4 (2425.64): C 49.52, H 3.63, N 2.31; found: C 51.20, H 3.75, N 2.80.
Bis{m-[9,10-di(hydroxy-kO)anthracene-1,4-dionato(2)-kO1 :kO4]}bis{m-{4,4’-[(1E)-ethene-1,2-diyl]-
bis[pyridine]-kN1 :kN1’}}tetrakis[(1,2,3,4,5,6-h)-1-methyl-4-(1-methylethyl)benzene]tetraruthenium 1,1,1-
Trifluoromethanesulfonate (1 :4) ([11] [CF3SO3]4): Yield 189 mg (74%). UV/VIS (1.0 · 105 m, acetone):
313 (3.75 · 105), 416 (0.35 · 105), 608 (0.14 · 105), 658 (0.16 · 105). IR: 3068w (nCsp2H), 1538s (nC¼O), 1260s
(nCsp3F), 850s (dCsp2H).
1H-NMR (400 MHz, CD3CN): 8.60 – 8.66 (m, 4 HdhaqþHdhaq’); 8.33 (d, 3J¼ 8.4,
8 Ha); 7.90 – 7.94 (m, 4 HdhaqþHdhaq’); 7.38 (d, 3J¼ 8.4, 8 Hb); 7.23 (s, 4 HC¼C); 7.18 (s, 2 Hdhaq); 7.17 (s,
2 Hdhaq’); 5.76 (d, 3J¼ 5.6, 4 Hp-cym); 5.69 (d, 3J¼ 5.6, 4 Hp-cym); 5.53 (d, 3J¼ 5.6, 4 Hp-cym); 5.51 (d, 3J¼ 5.6,
4 Hp-cym); 2.85 (sept., 3J¼ 2.8, 4 Me2CH); 2.11 (s, 4 Me); 1.29 (d, 3J¼ 2.8, 4Me2CH). 13C-NMR (100 MHz,
CD3CN): 171.3 (CO); 170.4 (CO); 153.1 (CHa); 146.8 (Cethene); 138.6 (CHdhaq); 134.2 (CHdhaq); 134.1
(Cdhaq); 132.0 (Cdhaq); 128.3 (CHdhaq); 128.2 (CH¼CH); 124.1 (CHb); 110.6 (CF3); 104.5 (Cp-cym); 100.3
(Cp-cym); 85.1 (CHp-cym); 84.8 (CHp-cym); 83.8 (CHp-cym); 83.7 (CHp-cym); 31.4 (Me2CH); 22.5 (Me2CH); 17.6




1,1,1-Trifluoromethanesulfonate (1 :4) ([12] [CF3SO3]4): Yield 199 mg (75%). UV/VIS (1.0 · 105 m,
acetone): 315 (3.84 · 105), 382 (0.46 · 105), 531 (0.12 · 105), 570 (0.20 · 105), 618 (0.24 · 105). IR: 3070w
(nCsp2H), 1543s (nC¼O), 1259s (nCsp3F), 850s (dCsp2H).
1H-NMR (400 MHz, CD3CN): 8.69 (d, 3J¼ 8.6,
8 Hdhtq); 8.37 (d, 3J¼ 7.9, 8 Ha); 7.92 (d, 3J¼ 8.6, 8 Hdhtq); 7.30 (d, 3J¼ 7.9, 8 Hb); 7.14 (s, 4 HC¼C); 5.81 (d,
3J¼ 5.6, 8 Hp-cym); 5.60 (d, 3J¼ 5.6, 8 Hp-cym); 2.90 (sept., 3J¼ 2.9, 4 Me2CH); 2.13 (s, 4 Me); 1.28 (d, 3J¼
2.9, 4Me2CH). 13C-NMR (100 MHz, CD3CN): 170.4 (CO); 153.0 (CHa); 146.8 (Cethylene); 134.6 (CHdhtq);
133.9 (Cdhtq); 133.8 (Cdhtq); 131.9 (CHdhtq); 128.1 (CH¼CH); 124.1 (CHb); 100.4 (Cp-cym); 84.9 (CHp-cym);
83.5 (CHp-cym); 31.4 (Me2CH); 22.5 (Me2CH); 17.9 (Me). Anal. calc. for C104H92F12N4O20Ru4S4 (2477.69):
C 50.41, H 3.71, N 2.26; found: C 48.22, H 3.51, N 2.38.
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